ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2023

Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study.

Katharina Fink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.